Venker Eric

Insider

President & Immunovant CEO

Trades at: ROIV· IMVT

30D 90D 1Y

Net shares · 365d

-5.2M

0 buy · 5.2M sell

Net value · 365d

-$97.2M

$0 in · $97.2M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 5.2M sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 365d

Open-market Buys Sells All types

ROIV Exercise·M
May 22, 26

President & Immunovant CEO · 10b5-1

$0

200.0K sh

Own +5%
ROIV Sell·S
May 22, 26

President & Immunovant CEO · 10b5-1

$6.1M

200.0K sh · $30.27

Own -11%
ROIV Exercise·M
May 22, 26

President & Immunovant CEO · 10b5-1

$770.0K

200.0K sh · $3.85

Own +12%
ROIV Other·F
May 20, 26

President & Immunovant CEO · 10b5-1

$1.1M

34.5K sh · $32.41

Own -2%
ROIV Exercise·M
Apr 20, 26

President & Immunovant CEO · 10b5-1

$0

200.0K sh

Own +4%
ROIV Sell·S
Apr 20, 26

President & Immunovant CEO · 10b5-1

$5.9M

200.0K sh · $29.59

Own -11%
ROIV Exercise·M
Apr 20, 26

President & Immunovant CEO · 10b5-1

$770.0K

200.0K sh · $3.85

Own +12%
IMVT Grant·A
Apr 7, 26

Chief Executive Officer

$0

336.0K sh

Own New
IMVT Grant·A
Apr 7, 26

Chief Executive Officer

$0

232.3K sh

Own +1187%
IMVT Sell·S
Apr 2, 26

Chief Executive Officer

$342.9K

14.2K sh · $24.10 avg · 2 lots

Own -42%
IMVT Exercise·M
Apr 1, 26

Chief Executive Officer

$0

368.8K sh

Own +50%
IMVT Other·D
Apr 1, 26

Chief Executive Officer

$8.4M

335.0K sh · $25.10

Own -91%
IMVT Exercise·M
Apr 1, 26

Chief Executive Officer

$5.3M

368.8K sh · $14.46

Own New
ROIV Exercise·M
Mar 17, 26

President & Immunovant CEO · 10b5-1

$0

200.0K sh

Own +4%
ROIV Exercise·M
Mar 17, 26

President & Immunovant CEO · 10b5-1

$770.0K

200.0K sh · $3.85

Own +12%
ROIV Sell·S
Mar 17, 26

President & Immunovant CEO · 10b5-1

$5.6M

200.0K sh · $28.24

Own -11%
ROIV Other·F
Feb 20, 26

President & Immunovant CEO

$191.4K

7.1K sh · $27.15

Own -0%
ROIV Exercise·M
Feb 13, 26

President & Immunovant CEO · 10b5-1

$0

200.0K sh

Own +4%
ROIV Exercise·M
Feb 13, 26

President & Immunovant CEO · 10b5-1

$770.0K

200.0K sh · $3.85

Own +12%
ROIV Sell·S
Feb 13, 26

President & Immunovant CEO · 10b5-1

$5.3M

200.0K sh · $26.49

Own -11%
ROIV Exercise·M
Jan 12, 26

President & Immunovant CEO · 10b5-1

$0

200.0K sh

Own +4%
ROIV Exercise·M
Jan 12, 26

President & Immunovant CEO · 10b5-1

$770.0K

200.0K sh · $3.85

Own +12%
ROIV Sell·S
Jan 12, 26

President & Immunovant CEO · 10b5-1

$4.4M

200.0K sh · $21.92

Own -11%
ROIV Exercise·M
Dec 24, 25

President & Immunovant CEO

$0

431.7K sh · 2 lots

Own +9%
ROIV Exercise·M
Dec 24, 25

President & Immunovant CEO

$1.7M

431.7K sh · $3.85 avg · 2 lots

Own +33%
ROIV Sell·S
Dec 24, 25

President & Immunovant CEO

$6.2M

275.0K sh · $22.47 avg · 2 lots

Own -14%
ROIV Exercise·M
Dec 9, 25

President & Immunovant CEO · 10b5-1

$0

200.0K sh

Own +4%
ROIV Sell·S
Dec 9, 25

President & Immunovant CEO · 10b5-1

$4.2M

200.0K sh · $20.85

Own -12%
ROIV Exercise·M
Dec 9, 25

President & Immunovant CEO · 10b5-1

$770.0K

200.0K sh · $3.85

Own +13%
ROIV Other·F
Nov 20, 25

President & Immunovant CEO

$142.9K

7.1K sh · $20.27

Own -0%
ROIV Exercise·M
Nov 7, 25

President & Immunovant CEO · 10b5-1

$4.0M

200.0K sh · $20.22

Own +3%
ROIV Sell·S
Nov 7, 25

President & Immunovant CEO · 10b5-1

$4.0M

200.0K sh · $20.22

Own -12%
ROIV Exercise·M
Nov 7, 25

President & Immunovant CEO · 10b5-1

$770.0K

200.0K sh · $3.85

Own +13%
ROIV Exercise·M
Oct 17, 25

President & Immunovant CEO · 10b5-1

$0

851.4K sh · 3 lots

Own New
ROIV Exercise·M
Oct 17, 25

President & Immunovant CEO · 10b5-1

$13.5M

851.4K sh · $15.85 avg · 3 lots

Own +110%
ROIV Sell·S
Oct 17, 25

President & Immunovant CEO · 10b5-1

$14.5M

851.4K sh · $16.99 avg · 3 lots

Own -36%
ROIV Exercise·M
Oct 13, 25

President & Immunovant CEO · 10b5-1

$0

125.7K sh · 2 lots

Own +17%
ROIV Exercise·M
Oct 13, 25

President & Immunovant CEO · 10b5-1

$2.0M

125.7K sh · $15.85 avg · 2 lots

Own +9%
ROIV Sell·S
Oct 13, 25

President & Immunovant CEO · 10b5-1

$2.0M

125.7K sh · $16.29 avg · 2 lots

Own -8%
ROIV Exercise·M
Oct 8, 25

President & Immunovant CEO · 10b5-1

$0

665.2K sh · 8 lots

Own +213%
ROIV Sell·S
Oct 8, 25

President & Immunovant CEO · 10b5-1

$10.8M

665.2K sh · $16.21 avg · 3 lots

Own -31%
ROIV Exercise·M
Oct 8, 25

President & Immunovant CEO · 10b5-1

$6.0M

665.2K sh · $8.95 avg · 8 lots

Own +68%
ROIV Sell·S
Sep 23, 25

President & Immunovant CEO · 10b5-1

$25.5M

1.7M sh · $14.92 avg · 4 lots

Own -53%
ROIV Exercise·M
Sep 22, 25

President & Immunovant CEO · 10b5-1

$0

1.6M sh · 3 lots

Own +31%
ROIV Exercise·M
Sep 22, 25

President & Immunovant CEO · 10b5-1

$6.0M

1.6M sh · $3.85 avg · 3 lots

Own +161%
ROIV Exercise·M
Aug 20, 25

President & Immunovant CEO · 10b5-1

$0

100.0K sh

Own +1%
ROIV Other·F
Aug 20, 25

President & Immunovant CEO · 10b5-1

$82.6K

7.1K sh · $11.72

Own -0%
ROIV Sell·S
Aug 20, 25

President & Immunovant CEO · 10b5-1

$1.2M

100.0K sh · $11.72

Own -6%
ROIV Exercise·M
Aug 20, 25

President & Immunovant CEO · 10b5-1

$385.0K

100.0K sh · $3.85

Own +6%
ROIV Grant·A
Jul 30, 25

President & Immunovant CEO

$0

198.4K sh

Own +14%
IMVT Grant·A
Jul 28, 25

Chief Executive Officer

$0

3.0M sh · 3 lots

Own New
ROIV Exercise·M
Jul 21, 25

President & Immunovant CEO · 10b5-1

$0

100.0K sh

Own +1%
ROIV Exercise·M
Jul 21, 25

President & Immunovant CEO · 10b5-1

$385.0K

100.0K sh · $3.85

Own +7%
ROIV Sell·S
Jul 21, 25

President & Immunovant CEO · 10b5-1

$1.2M

100.0K sh · $11.52

Own -6%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
May 22, 2026	ROIV	President & Immunovant CEO	Exercise M	200.0K	+5%	—	$0
May 22, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$30.27	$6.1M
May 22, 2026	ROIV	President & Immunovant CEO	Exercise M	200.0K	+12%	$3.85	$770.0K
May 20, 2026	ROIV	President & Immunovant CEO	Other F	34.5K	-2%	$32.41	$1.1M
Apr 20, 2026	ROIV	President & Immunovant CEO	Exercise M	200.0K	+4%	—	$0
Apr 20, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$29.59	$5.9M
Apr 20, 2026	ROIV	President & Immunovant CEO	Exercise M	200.0K	+12%	$3.85	$770.0K
Apr 7, 2026	IMVT	Chief Executive Officer	Grant A	336.0K	New	—	$0
Apr 7, 2026	IMVT	Chief Executive Officer	Grant A	232.3K	+1187%	—	$0
Apr 2, 2026	IMVT	Chief Executive Officer	Sell S	14.2K2 lots	-42%	$24.10 avg	$342.9K
Apr 1, 2026	IMVT	Chief Executive Officer	Exercise M	368.8K	+50%	—	$0
Apr 1, 2026	IMVT	Chief Executive Officer	Other D	335.0K	-91%	$25.10	$8.4M
Apr 1, 2026	IMVT	Chief Executive Officer	Exercise M	368.8K	New	$14.46	$5.3M
Mar 17, 2026	ROIV	President & Immunovant CEO	Exercise M	200.0K	+4%	—	$0
Mar 17, 2026	ROIV	President & Immunovant CEO	Exercise M	200.0K	+12%	$3.85	$770.0K
Mar 17, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$28.24	$5.6M
Feb 20, 2026	ROIV	President & Immunovant CEO	Other F	7.1K	-0%	$27.15	$191.4K
Feb 13, 2026	ROIV	President & Immunovant CEO	Exercise M	200.0K	+4%	—	$0
Feb 13, 2026	ROIV	President & Immunovant CEO	Exercise M	200.0K	+12%	$3.85	$770.0K
Feb 13, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$26.49	$5.3M
Jan 12, 2026	ROIV	President & Immunovant CEO	Exercise M	200.0K	+4%	—	$0
Jan 12, 2026	ROIV	President & Immunovant CEO	Exercise M	200.0K	+12%	$3.85	$770.0K
Jan 12, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$21.92	$4.4M
Dec 24, 2025	ROIV	President & Immunovant CEO	Exercise M	431.7K2 lots	+9%	—	$0
Dec 24, 2025	ROIV	President & Immunovant CEO	Exercise M	431.7K2 lots	+33%	$3.85 avg	$1.7M
Dec 24, 2025	ROIV	President & Immunovant CEO	Sell S	275.0K2 lots	-14%	$22.47 avg	$6.2M
Dec 9, 2025	ROIV	President & Immunovant CEO	Exercise M	200.0K	+4%	—	$0
Dec 9, 2025	ROIV	President & Immunovant CEO	Sell S	200.0K	-12%	$20.85	$4.2M
Dec 9, 2025	ROIV	President & Immunovant CEO	Exercise M	200.0K	+13%	$3.85	$770.0K
Nov 20, 2025	ROIV	President & Immunovant CEO	Other F	7.1K	-0%	$20.27	$142.9K
Nov 7, 2025	ROIV	President & Immunovant CEO	Exercise M	200.0K	+3%	$20.22	$4.0M
Nov 7, 2025	ROIV	President & Immunovant CEO	Sell S	200.0K	-12%	$20.22	$4.0M
Nov 7, 2025	ROIV	President & Immunovant CEO	Exercise M	200.0K	+13%	$3.85	$770.0K
Oct 17, 2025	ROIV	President & Immunovant CEO	Exercise M	851.4K3 lots	New	—	$0
Oct 17, 2025	ROIV	President & Immunovant CEO	Exercise M	851.4K3 lots	+110%	$15.85 avg	$13.5M
Oct 17, 2025	ROIV	President & Immunovant CEO	Sell S	851.4K3 lots	-36%	$16.99 avg	$14.5M
Oct 13, 2025	ROIV	President & Immunovant CEO	Exercise M	125.7K2 lots	+17%	—	$0
Oct 13, 2025	ROIV	President & Immunovant CEO	Exercise M	125.7K2 lots	+9%	$15.85 avg	$2.0M
Oct 13, 2025	ROIV	President & Immunovant CEO	Sell S	125.7K2 lots	-8%	$16.29 avg	$2.0M
Oct 8, 2025	ROIV	President & Immunovant CEO	Exercise M	665.2K8 lots	+213%	—	$0
Oct 8, 2025	ROIV	President & Immunovant CEO	Sell S	665.2K3 lots	-31%	$16.21 avg	$10.8M
Oct 8, 2025	ROIV	President & Immunovant CEO	Exercise M	665.2K8 lots	+68%	$8.95 avg	$6.0M
Sep 23, 2025	ROIV	President & Immunovant CEO	Sell S	1.7M4 lots	-53%	$14.92 avg	$25.5M
Sep 22, 2025	ROIV	President & Immunovant CEO	Exercise M	1.6M3 lots	+31%	—	$0
Sep 22, 2025	ROIV	President & Immunovant CEO	Exercise M	1.6M3 lots	+161%	$3.85 avg	$6.0M
Aug 20, 2025	ROIV	President & Immunovant CEO	Exercise M	100.0K	+1%	—	$0
Aug 20, 2025	ROIV	President & Immunovant CEO	Other F	7.1K	-0%	$11.72	$82.6K
Aug 20, 2025	ROIV	President & Immunovant CEO	Sell S	100.0K	-6%	$11.72	$1.2M
Aug 20, 2025	ROIV	President & Immunovant CEO	Exercise M	100.0K	+6%	$3.85	$385.0K
Jul 30, 2025	ROIV	President & Immunovant CEO	Grant A	198.4K	+14%	—	$0
Jul 28, 2025	IMVT	Chief Executive Officer	Grant A	3.0M3 lots	New	—	$0
Jul 21, 2025	ROIV	President & Immunovant CEO	Exercise M	100.0K	+1%	—	$0
Jul 21, 2025	ROIV	President & Immunovant CEO	Exercise M	100.0K	+7%	$3.85	$385.0K
Jul 21, 2025	ROIV	President & Immunovant CEO	Sell S	100.0K	-6%	$11.52	$1.2M

Buy Sell Non-market (grant · exercise · gift)

About Venker Eric

This profile aggregates every SEC Form 4 insider transaction reported by Venker Eric across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.